Abstract
The key elements that determine the host response to either the self-limited or a severe fulminant form of liver disease are unclear. We have investigated the potential association of single nucleotide polymorphisms (SNPs) in the promoter region of tumor necrosis factor-alpha (TNFα) in their susceptibility to acute viral hepatitis (AVH) and fulminant hepatic failure (FHF) patients exhibiting specific viral etiology. A total of 124 individuals including 64 cases comprising 27 FHF, 37 AVH, and 60 healthy controls were recruited. SNPs at −238 (G/A), −308 (G/A), −857 (C/T), and −863 (C/A) of TNFα were detected by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) and confirmed by direct sequencing. Serum levels of TNFα were determined at admission and death or recovery. Association between the TNFα genotype and susceptibility to FHF was not evident; however, carrier genotypes in relation to the −308 (GA/AA) and −857 (CT/TT) loci were found to be significantly (P ≤ 0.05) associated with susceptibility to AVH in relation to controls. The mean TNFα serum levels at admission were significantly higher (P < 0.001) in FHF than AVH patients, but no marked difference was observed between FHF-E (expired; n = 17) and FHF-S (survivors; n = 10), though the former were comparatively higher. This study suggests that SNPs at −308 and −857 of the TNFα promoter may represent an increased risk for the development of AVH but not for FHF in the Indian population.
Similar content being viewed by others
References
Sallie R, Silva AE, Purdy M, et al. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol. 1994;20(5):580–588. doi:10.1016/S0168-8278(05)80343-5.
Lidofsky SD, Bass NM, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992;16(1):1–7. doi:10.1002/hep.1840160102.
Vickers C, Neuberger J, Buckels J, et al. Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol. 1988;7(2):143–150. doi:10.1016/S0168-8278(88)80475-6.
Ostapowicz G, Fontana RJ, Schiodt FV, et al; U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–954.
Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. 1999;5(1):29–34. doi:10.1002/lt.500050102.
Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23(6):1448–1455. doi:10.1002/hep.510230622.
Dhiman RK, Seth AK, Jain S, et al. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci. 1998;43(6):1311–1316. doi:10.1023/A:1018876328561.
Kar P, Budhiraja S, Narang A, et al. Etiology of sporadic acute and fulminant non-A, non-B viral hepatitis in north India. Indian J Gastroenterol. 1997;16(2):43–45.
Acharya SK, Panda SK, Saxena A, et al. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol. 2000;15(5):473–479. doi:10.1046/j.1440-1746.2000.02073.x.
de la Mata M, Meager A, Rolando N, et al. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol. 1990;82(3):479–484.
Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol. 1994;98(1):71–77.
Wilson AG, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177(2):557–560. doi:10.1084/jem.177.2.557.
Stüber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med. 1996;24:381–384. doi:10.1097/00003246-199603000-00004.
Cookson S, Constantini PK, Clare M, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology. 1999;30(4):851–856. doi:10.1002/hep.510300412.
Ho SY, Wang YJ, Chen HL, et al. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the −308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control. 2004;15(7):657–663. doi:10.1023/B:CACO.0000036173.99930.75.
Grove J, Daly AK, Bassendine MF, et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 1997;26(1):143–146. doi:10.1002/hep.510260119.
Kim YJ, Lee HS, Yoon JH, et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet. 2003;12(19):2541–2546. doi:10.1093/hmg/ddg262.
Li HQ, Li Z, Liu Y, et al. Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J Gastroenterol. 2005;11(33):5213–5217.
Lu LP, Li XW, Liu Y, et al. Association of −238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol. 2004;10(12):1810–1814.
Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005;11(1):52–56. doi:10.1111/j.1469-0691.2004.01029.x.
Heesen M, Kunz D, Wessiepe M, et al. Rapid genotyping for tumor necrosis factor-alpha (TNF-alpha) −863C/A promoter polymorphism that determines TNF-alpha response. Clin Chem. 2004;50(1):226–228. doi:10.1373/clinchem.2003.022962.
Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–298.
Smedile A, Farci P, Verme G, et al. Influence of delta infection on severity of Hepatitis B. Lancet. 1982;2:945–947. doi:10.1016/S0140-6736(82)90156-8.
Sambrook J, Fritsch E, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. USA: Cold Spring Harbor Laboratory Press; 1989.
Kohaar I, Thakur N, Salhan S, et al. TNFα–308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol. 2007;29(3):249–256.
Skoog T, Eriksson P, Hoffstedt J, et al. Tumour necrosis factor-alpha (TNF-alpha) polymorphisms −857C/A and −863C/A are associated with TNF-alpha secretion from human adipose tissue. Diabetologia. 2001;44(5):654–655. doi:10.1007/s001250051673.
O’Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445.
Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986;6:97–106. doi:10.1055/s-2008-1040593.
Singhal S, Kohaar I, Bharadwaj M, et al. Fas and TNF-alpha mediated apoptosis and TNF-alpha gene polymorphism in fulminant hepatic failure and its clinical relevance. Am J Gastroenterol. 2006;101(9):s151–s323.
Wilson AG, di Giovine FS, Duff GW. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm. 1995;45(1):1–12.
Takakura M, Tokushige K, Matsushita N, et al. Possible involvement of cytokine gene polymorphisms in fulminant hepatitis. J Gastroenterol Hepatol. 2007;22:1271–1277. doi:10.1111/j.1440-1746.2007.04846.x.
Bathgate AJ, Pravica V, Perrey C, et al. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol. 2000;12(12):1329–1333. doi:10.1097/00042737-200012120-00011.
Tsuchiya N, Tokushige K, Yamaguchi N, et al. Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis. J Gastroenterol. 2004;39(9):859–866. doi:10.1007/s00535-004-1402-1.
Tsai EY, Yie J, Thanos D, Goldfeld AE. Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol. 1996;16:5232–5244.
Perneger TV. What’s wrong with Bonferroni adjustments? BMJ. 1998;316(7139):1236–1238.
Acknowledgments
The study was supported by internal funding at the study centers. There are no conflicts of interest with any of the authors. The study has been presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course, Las Vegas, Nevada, October 2006. The manuscript has not been submitted or accepted elsewhere. All authors have contributed to, seen, and approved the final, submitted version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singhal, S., Kohaar, I., Bharadwaj, M. et al. Association of Tumor Necrosis Factor-Alpha Gene Promoter Polymorphisms with Acute Viral Hepatitis in the Indian Population. Dig Dis Sci 55, 1106–1112 (2010). https://doi.org/10.1007/s10620-009-0799-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-0799-z